{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:20:03Z","timestamp":1728447603574},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,8]]},"DOI":"10.7759\/cureus.71055","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T08:08:36Z","timestamp":1728374916000},"source":"Crossref","is-referenced-by-count":0,"title":["Factors Involved in the Development of Diabetic Kidney Disease in Patients With Slowly Progressive Type 1 Diabetes Mellitus: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Hideyuki","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA consensus conference","volume":"37","author":"Tuttle KR","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, et al.. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014, 37:2864-83. 10.2337\/dc14-1296","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000084286","article-title":"Diabetic nephropathy: the proteinuria hypothesis","volume":"25","author":"Williams ME","year":"2005","unstructured":"Williams ME. Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol. 2005, 25:77-94. 10.1159\/000084286","journal-title":"Am J Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014","volume":"316","author":"Afkarian M","year":"2016","unstructured":"Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. 2016, 316:602-10. 10.1001\/jama.2016.10924","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go AS","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351:1296-305. 10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00523.x","article-title":"Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes","volume":"68","author":"Pavkov ME","year":"2005","unstructured":"Pavkov ME, Bennett PH, Sievers ML, Krakoff J, Williams DE, Knowler WC, Nelson RG. Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes. Kidney Int. 2005, 68:1267-74. 10.1111\/j.1523-1755.2005.00523.x","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1543","article-title":"The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"Groop PH","year":"2009","unstructured":"Groop PH, Thomas MC, Moran JL, et al.. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009, 58:1651-8. 10.2337\/db08-1543","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12533","article-title":"Clinical predictive factors in diabetic kidney disease progression","volume":"8","author":"Radcliffe NJ","year":"2017","unstructured":"Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig. 2017, 8:6-18. 10.1111\/jdi.12533","journal-title":"J Diabetes Investig"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2062","article-title":"Risk factors for kidney disease in type 1 diabetes","volume":"42","author":"Perkins BA","year":"2019","unstructured":"Perkins BA, Bebu I, de Boer IH, et al.. Risk factors for kidney disease in type 1 diabetes. Diabetes Care. 2019, 42:883-90. 10.2337\/dc18-2062","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2015.11.008","article-title":"Incidence and risk factors involved in the development of nephropathy in patients with type 1 diabetes mellitus: follow up since onset","volume":"40","author":"Go\u00f1i MJ","year":"2016","unstructured":"Go\u00f1i MJ, Forga L, Iba\u00f1ez B, Cambra K, Mozas D, Anda E. Incidence and risk factors involved in the development of nephropathy in patients with type 1 diabetes mellitus: follow up since onset. Can J Diabetes. 2016, 40:258-63. 10.1016\/j.jcjd.2015.11.008","journal-title":"Can J Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonz\u00e1lez JF","year":"2008","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008, 19:433-42. 10.1681\/ASN.2007091048","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2563","article-title":"hs-CRP is associated with incident diabetic nephropathy: findings from the Jackson Heart Study","volume":"42","author":"Sinha SK","year":"2019","unstructured":"Sinha SK, Nicholas SB, Sung JH, Correa A, Rajavashisth TB, Norris KC, Lee JE. hs-CRP is associated with incident diabetic nephropathy: findings from the Jackson Heart Study. Diabetes Care. 2019, 42:2083-9. 10.2337\/dc18-2563","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2012.06.016","article-title":"Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients","volume":"27","author":"Overgaard AJ","year":"2013","unstructured":"Overgaard AJ, McGuire JN, Hovind P, Parving HH, Rossing P, Pociot F. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients. J Diabetes Complications. 2013, 27:59-63. 10.1016\/j.jdiacomp.2012.06.016","journal-title":"J Diabetes Complications"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.08.022","article-title":"Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes","volume":"31","author":"Duvnjak L","year":"2017","unstructured":"Duvnjak L, Perkovi\u0107 MN, Blaslov K. Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes. J Diabetes Complications. 2017, 31:218-22. 10.1016\/j.jdiacomp.2016.08.022","journal-title":"J Diabetes Complications"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1479164115615356","article-title":"Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study","volume":"13","author":"Zheng T","year":"2016","unstructured":"Zheng T, Liu Y, Qin S, Liu H, Zhang X, Zhao H. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study. Diab Vasc Dis Res. 2016, 13:127-36. 10.1177\/1479164115615356","journal-title":"Diab Vasc Dis Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.5.780","article-title":"Immunogenetic and clinical characterization of slowly progressive IDDM","volume":"16","author":"Kobayashi T","year":"1993","unstructured":"Kobayashi T, Tamemoto K, Nakanishi K, et al.. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care. 1993, 16:780-8. 10.2337\/diacare.16.5.780","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14121","article-title":"New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)","volume":"15","author":"Shimada A","year":"2024","unstructured":"Shimada A, Kawasaki E, Abiru N, et al.. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version). J Diabetes Investig. 2024, 15:254-7. 10.1111\/jdi.14121","journal-title":"J Diabetes Investig"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02562.x","article-title":"Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study","volume":"25","author":"Myhill P","year":"2008","unstructured":"Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TM. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med. 2008, 25:1245-50. 10.1111\/j.1464-5491.2008.02562.x","journal-title":"Diabet Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1479164121989281","article-title":"Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals","volume":"18","author":"Nakamura S","year":"2021","unstructured":"Nakamura S, Mori K, Okuma H, Sekine T, Miyazaki A, Tsuchiya K. Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals. Diab Vasc Dis Res. 2021, 18:1479164121989281. 10.1177\/1479164121989281","journal-title":"Diab Vasc Dis Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-0949-2","article-title":"Evidence-based clinical practice guideline for CKD 2013","volume":"18","year":"2014","unstructured":"Evidence-based clinical practice guideline for CKD 2013. Clin Exp Nephrol. 2014, 18.346-423. 10.1007\/s10157-014-0949-2","journal-title":"Clin Exp Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.jpbs_290_21","article-title":"Assessment of correlation of serum high-sensitive C-reactive protein, urinary albumin-to-creatinine ratio, and lipid profile in diabetics","volume":"13","author":"Kumari S","year":"2021","unstructured":"Kumari S, Singh B. Assessment of correlation of serum high-sensitive C-reactive protein, urinary albumin-to-creatinine ratio, and lipid profile in diabetics. J Pharm Bioallied Sci. 2021, 13:S1569-72. 10.4103\/jpbs.jpbs_290_21","journal-title":"J Pharm Bioallied Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.10.048","article-title":"Markers of and risk factors for the development and progression of diabetic kidney disease","volume":"63","author":"Macisaac RJ","year":"2014","unstructured":"Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014, 63:S39-62. 10.1053\/j.ajkd.2013.10.048","journal-title":"Am J Kidney Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07230-8","article-title":"Analysis of inflammatory cytokine and TLR expression levels in Type 2 diabetes with complications","volume":"7","author":"Gupta S","year":"2017","unstructured":"Gupta S, Maratha A, Siednienko J, Natarajan A, Gajanayake T, Hoashi S, Miggin S. Analysis of inflammatory cytokine and TLR expression levels in Type 2 diabetes with complications. Sci Rep. 2017, 7:7633. 10.1038\/s41598-017-07230-8","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000041","article-title":"High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease","volume":"93","author":"Huang WH","year":"2014","unstructured":"Huang WH, Chen CY, Lin JL, Lin-Tan DT, Hsu CW, Yen TH. High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease. Medicine (Baltimore). 2014, 93:e41. 10.1097\/MD.0000000000000041","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0190","article-title":"Derivation and validation of a renal risk score for people with type 2 diabetes","volume":"36","author":"Elley CR","year":"2013","unstructured":"Elley CR, Robinson T, Moyes SA, et al.. Derivation and validation of a renal risk score for people with type 2 diabetes. Diabetes Care. 2013, 36:3113-20. 10.2337\/dc13-0190","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v3.i1.7","article-title":"Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy","volume":"3","author":"Luis-Rodr\u00edguez D","year":"2012","unstructured":"Luis-Rodr\u00edguez D, Mart\u00ednez-Castelao A, G\u00f3rriz JL, De-\u00c1lvaro F, Navarro-Gonz\u00e1lez JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes. 2012, 3:7-18. 10.4239\/wjd.v3.i1.7","journal-title":"World J Diabetes"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0030","article-title":"Soluble dipeptidyl peptidase-4 levels are associated with decreased renal function in patients with type 2 diabetes mellitus","volume":"43","author":"Cho EH","year":"2019","unstructured":"Cho EH, Kim SW. Soluble dipeptidyl peptidase-4 levels are associated with decreased renal function in patients with type 2 diabetes mellitus. Diabetes Metab J. 2019, 43:97-104. 10.4093\/dmj.2018.0030","journal-title":"Diabetes Metab J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.08.017","article-title":"DPP4\/CD32b\/NF-\u03baB circuit: a novel druggable target for inhibiting CRP-driven diabetic nephropathy","volume":"29","author":"Tang PM","year":"2021","unstructured":"Tang PM, Zhang YY, Hung JS, Chung JY, Huang XR, To KF, Lan HY. DPP4\/CD32b\/NF-\u03baB circuit: a novel druggable target for inhibiting CRP-driven diabetic nephropathy. Mol Ther. 2021, 29:365-75. 10.1016\/j.ymthe.2020.08.017","journal-title":"Mol Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0621","article-title":"Effect of saxagliptin on renal outcomes in the SAVOR-TIMI 53 Trial","volume":"40","author":"Mosenzon O","year":"2017","unstructured":"Mosenzon O, Leibowitz G, Bhatt DL, et al.. Effect of saxagliptin on renal outcomes in the SAVOR-TIMI 53 Trial. Diabetes Care. 2017, 40:69-76. 10.2337\/dc16-0621","journal-title":"Diabetes Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13041","article-title":"Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial","volume":"19","author":"Groop PH","year":"2017","unstructured":"Groop PH, Cooper ME, Perkovic V, et al.. Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial. Diabetes Obes Metab. 2017, 19:1610-9. 10.1111\/dom.13041","journal-title":"Diabetes Obes Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers D","year":"2011","unstructured":"Lamers D, Famulla S, Wronkowitz N, et al.. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011, 60:1917-25. 10.2337\/db10-1707","journal-title":"Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300479-factors-involved-in-the-development-of-diabetic-kidney-disease-in-patients-with-slowly-progressive-type-1-diabetes-mellitus-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T08:08:40Z","timestamp":1728374920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300479-factors-involved-in-the-development-of-diabetic-kidney-disease-in-patients-with-slowly-progressive-type-1-diabetes-mellitus-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.71055","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}